High plasma activity of endogenous antioxidants protect CD4+ T-cells in HIV-serodiscordant heterosexual partners in a Nigerian population

International Journal of STD and AIDS

Volumn 19, Issue 8, 2008, Pages 536-540

  Ibeh, Bartholomew O ^a,b   Obidoa, Onyechi ^a   Uzoegwu, Peter N ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b MICHAEL OKPARA UNIVERSITY OF AGRICULTURE   (Nigeria)

Author keywords

CAT; CD4; GHPX; GST; HIV; Serodiscordant; SOD

Indexed keywords

ANTIOXIDANT; CATALASE; CD3 ANTIGEN; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HETEROSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NIGER; PRIORITY JOURNAL; SCREENING TEST; SPECTROPHOTOMETER;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; CATALASE; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HETEROSEXUALITY; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MALE; NIGERIA; SEXUAL PARTNERS; SUPEROXIDE DISMUTASE;

EID: 49449100673     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008031     Document Type: Article

References (36)

1. Migueles SA, Laborico AC, Imamichc H, et al. The differential ability of HLAB* 5701 + long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral jag sequences. J Virol 2003;77;6889-98
2. Theodorou I, Meyer L, Magierowskg M, katlama C, Rouzious C. HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco study group. Lancet 1997;349:1219-20
3. Harrigan PR, Bloor S, Larder BA. Relative replicative fitness of zidovudine-resistance human immunodeficiency virus type 1 isolates in vitro. J Virol 1998;72:3773-8
4. Learmont JC. Immunologic and virologic status after 14-18 years of infection with an alternative strain of HIV-1. N Engl J Med 1999;340:1715-22
5. Coakley E, Petropoulos CJ, Whitecomb JM. Assessing chemokine co-receptor usage in HIV. Curr Opin Infect Dis 2005;18:9-15
6. Gougeon ML, Montagnier L. HIV infection progression. Science 1993;260:1269-72
7. Chochola J, Strosberg AD, Stanislawski M. Release of hydrogen peroxide from human T cell lines and normal lymphocytes co-infected with HIV-1 and mycoplasma. Free Radic Res Commun 1995;23:197-212
8. Arai S, Munakata T, Kuwano K. Mycoplasma interaction with lymphocytes and phagocytes: role of H2O2 released from M.Pneumoniae. Yale J Biol Med 1983;56:631-8
9. Clopton Ek, Saltman P. Low-level oxidation stress causes cell cycle specific arrest in cultured cells. Biochem Biophys Res Commun 1995;210:189-196
10. Sen CK, Packer L. Antioxidant and redox regulation of gene translation. FASEB J 1996;6:607-20
11. Bonfoco E, Krainc D, Ankarcronia M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995;92:7162-6
12. Vaya J, Aviriam M. Nutritional antioxidants: mechanisms of action, analysis of activities and medical applications. Cure Med Chem Imm Endoc & Metab Agents 2001;1:99-117
13. Lewin S. Vitamin C: its Molecular Biology and Medical Potential. New York, USA: Academic press, 1976:42-56
14. Pagamara AT, Perno CF, Aquaro S, Bue MC, Dini L, Geraci E. Glutathione inhibits HIV replication by acting at later stage of the virus life cycle. AIDS Res Hum Retro 1996;2:1537-41
15. Flores SC, Marecki K, Harper SW, Bose SK, Nelson SK, Mc Cord JC. Tat Protein of HIV-1 represses expression of manganese superoxide dismutase in Hela cells. Proc Natl Acad Sci USA 1993;90:7627-36
16. Liedias FP, Hansberg W. Oxidation of catalase by singlet oxygen. J Biol Chem 1998;273:10630-7
17. Centers for Disease Control and Prevention (CDC). 1993 Revised classification system for HIV infection and expanded surveillance, case definition for AIDS among adolescents and adults. MMWR 1992;41:1-19
18. WHO International collaborating Group for the study of the WHO staging System. WHO Staging System for HIV infection and disease. AIDS 1993;7:711-8
19. Cohen G, Dembiee D, Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem 1970;34:30-8
20. McCord JM, Fridovich I. Superoxide dismutase enzyme function for erythrocuprein (hemeocupre). J Biol Chem 1969;244:6049-55
21. Boveris A, Chance B. Method for determining oxidized and reduced glutathione in tissues- J Biochem 1973;134:707-16
22. Wendel A. Enzymatic Basis of Detoxification. New York: Academic press, 1980;1:333-53
23. Habig WH, Passt MT, Jakoby WB. Glutathione transferase, the first enzyme steps in mecapturic acid formation. J Biochem 1974;249:7130-9
24. De Vincenzi A. Longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 1994;331:341-6
25. European study group on heterosexual transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ 1992;304:809-13
26. Nicolosi A, Correa-Leite ML, Musicco M, Arici C, Gavazzeni G, Lazarrin A. The efficiency of male to female and female to male sexual transmission of the human immunodeficiency Virus. A study of 730 stable couples. Epidemiology 1994;5:570-5
27. Royce RA, Sena A, Crates W, Cohen M. Current concepts: sexual transmission of HIV. N Engl J Med 1997;336:1072-9
28. Cocchi F, Devico Al, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha and MIP-I beta as the major HIV-suppressive factors produced by CD8 + T cells. Science 1995;270:1811-5
29. Oravcz T, Pall M, Norcoss MA. B-chemokine inhibitions of monocytrotropic HIV-1 infection interfere with a post binding fusing step. J Immunol 1996;157:1329-32
30. Favier A, Sappey C, Lecler C. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 1994;91:165-80
31. Taube R, Fujinaga K, Wimmer J, Barboric M, Peterlin BM. Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virol 1999;264:245-53
32. Zagury D, Lachgar A, Chams V, Gallo RC. Interferon alpha and tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci USA 1998a;95:3851-6
33. Zagury D, Lachgar A, Chams V, Gallo RC. C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci USA 1998b;95:3857-61
34. Westendrop MO, Shatrov VA, SchulzeOsthof K, et al. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J 1995;14:546-54
35. Schulze-Osthoff K, Baue MK, Vog M, Wesselborg S. Oxidative stress and signal transduction. Int Nut Res 1997;67:336-42
36. Ho WZ, Douglas SD Glutathione and N-acetyl cysteine suppression of human immunodeficiency virus replication in human monocyte/macrophages in vitro. AIDS Res Hum Retroviruses NW 1992;12:1035-8